Wafra Inc. Amgen Inc Transaction History

Wafra Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $4.13 Million - $4.99 Million	-15,370 Reduced 29.09%	37,472 $10.7 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $9.18 Million - $10.4 Million	-35,908 Reduced 40.46%	52,842 $15.2 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $15.4 Million - $19.2 Million	70,602 Added 389.03%	88,750 $23.9 Million
Q2 2023 Jul 21, 2023	BUY	$214.27 - $253.37 $3.89 Million - $4.6 Million	18,148 New	18,148 $4.03 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.